Achieve Life Sciences (ACHV) Cash from Investing Activities Growth (5y) (2015 - 2025)
Achieve Life Sciences (ACHV) Cash from Investing Activities Growth (5y) (2015 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
| 10 |
Achieve Life Sciences |
93.71 Mn |
63.22 Mn |
- |
| Date | Value |
|---|
| Sep 30, 2025 |
-430.91% |
| Jun 30, 2025 |
254.59% |
| Mar 31, 2025 |
463.44% |
| Dec 31, 2024 |
551.30% |
| Dec 31, 2023 |
72.34% |
| Sep 30, 2020 |
80.74% |
| Jun 30, 2020 |
-14.92% |
| Mar 31, 2020 |
-14.88% |
| Dec 31, 2019 |
85.21% |
| Jun 30, 2019 |
-23.34% |
| Mar 31, 2019 |
-29.73% |
| Dec 31, 2018 |
-19.18% |
| Sep 30, 2018 |
-18.28% |
| Jun 30, 2018 |
-14.92% |
| Mar 31, 2018 |
-75.46% |
| Dec 31, 2017 |
-55.86% |
| Sep 30, 2017 |
-26.59% |
| Jun 30, 2017 |
15.16% |
| Mar 31, 2017 |
20.35% |
| Dec 31, 2016 |
-9.56% |
